CJC-1295 w/o DAC/Ipamorelin Blend

📝 LAB NOTES

CJC-1295 (without DAC) 10mg + Ipamorelin 10mg is a dual-peptide research blend combining two compounds studied for their activity within growth hormone signaling pathways. CJC-1295 without DAC is a growth hormone-releasing hormone (GHRH) analog studied for its interaction with GHRH receptors, while Ipamorelin is a selective growth hormone secretagogue studied for its activity at the ghrelin receptor (GHS-R1a).

The combination is of research interest for investigating complementary mechanisms involved in pulsatile growth hormone release, endocrine signaling, IGF-1-related pathways, body composition, tissue recovery, protein metabolism, and lipid metabolism.

TARGETED RESEARCH USE

Growth hormone signaling, GHRH receptor activity, ghrelin receptor signaling, pulsatile GH secretion, IGF-1-related pathways, endocrine regulation, body-composition research, muscle-related biological processes, tissue recovery pathways, protein metabolism, lipid metabolism, and age-related changes in growth hormone signaling.

RESEARCH REFERENCES

• Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the First Selective Growth Hormone Secretagogue. European Journal of Endocrinology. 1998;139(5):552–561. — View Study on PubMed

• Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H. Ipamorelin, a New Growth-Hormone-Releasing Peptide, Induces Longitudinal Bone Growth in Rats. Growth Hormone & IGF Research. 1999;9(2):106–113. — View Study on PubMed

• Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged Stimulation of Growth Hormone and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of Growth Hormone-Releasing Hormone, in Healthy Adults. Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799–805. — View Study on PubMed

• Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YC, Felix AM. Rapid Enzymatic Degradation of Growth Hormone-Releasing Hormone by Plasma In Vitro and In Vivo to a Biologically Inactive Product Cleaved at the NH2 Terminus. Journal of Clinical Investigation. 1986;78(4):906–913. — View Study on PubMed

⚠️ FOR RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL USE

This research compound is supplied as a lyophilized powder in a sealed 3 mL vial to support stability and proper laboratory handling. Certificate of Analysis (COA) available for verification. Reconstitution is required prior to research use.